Odalasvir
- Generic Name
- Odalasvir
- Drug Type
- Small Molecule
- Chemical Formula
- C60H72N8O6
- CAS Number
- 1415119-52-6
- Unique Ingredient Identifier
- OVR52K7BDW
- Background
Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.
A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers
Phase 1
Completed
- Conditions
- Chronic Hepatitis C
- Interventions
- First Posted Date
- 2015-07-31
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Alios Biopharma Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT02512562
- Locations
- 🇫🇷
Biotrial, Rennes, France
Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants
Phase 2
Completed
- Conditions
- Hepatitis C, Chronic
- Interventions
- First Posted Date
- 2013-05-08
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01849562
Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants
Phase 1
Completed
- Conditions
- Chronic Hepatitis C Infection
- Interventions
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01700179
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath